Literature DB >> 9618153

Antagonistic regulation of cell migration by epidermal growth factor and glucocorticoid in human gastric carcinoma cells.

N Murakami1, S Fukuchi, K Takeuchi, T Hori, S Shibamoto, F Ito.   

Abstract

Epidermal growth factor (EGF) induced the disruption and scattering of colonies of TMK-1, a cell line derived from a human gastric carcinoma. A stimulatory action of EGF on cell migration was also observed as determined by a wound assay. However, these actions of EGF were inhibited if the cells were pretreated with dexamethasone, a synthetic glucocorticoid. Dexamethasone increased cell adhesion to collagen type IV and laminin, but not to poly-L-lysine and fibronectin. In contrast, EGF did not affect cell adhesion to these extracellular matrices whether dexamethasone was present or not. Dexamethasone enhanced the protein levels of both alpha1 and beta1 integrin subunits, and that of the alpha1 beta1 heterodimer. Further, flow cytometric analysis revealed that dexamethasone increased the expression of beta1 and alpha1 integrin subunits at the cell surface, whereas EGF increased expression of beta1 and alpha2 subunits at the cell surface. Antibodies against alpha1 and beta1 integrin subunits inhibited the increased cell adhesion seen in the presence of dexamethasone. An immunofluorescence study indicated that dexamethasone increased the formation of focal adhesions along the entire edges of cell colonies. In contrast, EGF led to the formation of focal adhesions preferentially at the cell front, and this EGF-induced preferential formation was not observed if the cells were pretreated with dexamethasone. These results suggest that glucocorticoid increased cell adhesion to the extracellular matrix via alpha1 beta1 integrin, and thereby antagonized EGF-induced cell migration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618153     DOI: 10.1002/(SICI)1097-4652(199807)176:1<127::AID-JCP15>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Poly(ε-caprolactone) and poly(D,L-lactic acid-co-glycolic acid) scaffolds used in bone tissue engineering prepared by melt compression-particulate leaching method.

Authors:  Samuel H Barbanti; Arnaldo R Santos; Cecília A C Zavaglia; Eliana A R Duek
Journal:  J Mater Sci Mater Med       Date:  2011-07-21       Impact factor: 3.896

2.  Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice.

Authors:  Lu Xia; Yao-Zong Yuan; Chun-Di Xu; Yong-Pin Zhang; Ming-Ming Qiao; Jia-Xu Xu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.

Authors:  Ines Macias-Perez; Corina Borza; Xiwu Chen; Xuexian Yan; Raquel Ibanez; Glenda Mernaugh; Lynn M Matrisian; Roy Zent; Ambra Pozzi
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors.

Authors:  Caroline Piette; Manuel Deprez; Thierry Roger; Agnès Noël; Jean-Michel Foidart; Carine Munaut
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

5.  Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional HDAC6 pathway.

Authors:  Stephen Kershaw; David J Morgan; James Boyd; David G Spiller; Gareth Kitchen; Egor Zindy; Mudassar Iqbal; Magnus Rattray; Christopher M Sanderson; Andrew Brass; Claus Jorgensen; Tracy Hussell; Laura C Matthews; David W Ray
Journal:  J Cell Sci       Date:  2020-06-11       Impact factor: 5.285

6.  Association of TNF-α with impaired migration capacity of mesenchymal stem cells in patients with systemic lupus erythematosus.

Authors:  Linyu Geng; Xia Li; Xuebing Feng; Jiyun Zhang; Dandan Wang; Jinyun Chen; Rui Liu; Haifeng Chen; Lingyun Sun
Journal:  J Immunol Res       Date:  2014-11-24       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.